acipimox [orch, phsu]
Primary [qlco]
Hyperlipidemias [dsyn]
Safety [hcpp]
Efficacy [qlco]
Efficacy [qlco]
Tolerance [fndg]
mg% [qnco]
acipimox [orch, phsu]
tested [inpr]
PTS [gngm]
Primary [qlco]
Type IV [clas]
PTS [gngm]
Diet [food]
recommendations [idcn]
national [inpr]
Cholesterol [bacs, strd]
educational program [edac]
Clinical examination [hlca]
eye fundus [blor]
Following [tmco]
Laboratory Tests [lbpr]
Total Cholesterol [lbpr]
Triglycerides [bacs, lipd]
Alkaline Phosphatase [aapp, enzy]
Transaminases [aapp, enzy]
Uric Acid [bacs, orch]
Creatinine [bacs, orch]
Albumin [aapp, bacs]
Postprandial [tmco]
glucose test [lbpr]
Haematocrit [lbpr]
White [popg]
Blood [tisu]
Platelet Count [lbpr]
Performed [ftcn]
days [tmco]
Drug [phsu]
Initiation [menp]
days [tmco]
treatment [ftcn]
Started [qlco]
side effects [ftcn]
Observed [ftcn]
Myositis [dsyn]
Visual [ftcn]
gastrointestinal [spco]
PTS [gngm]
Slight [qlco]
Moderate [qlco]
Flushing [sosy]
APPEAR [qlco]
days [tmco]
Last [qlco]
14 7 [qnco]
days [tmco]
treatment [ftcn]
Started [qlco]
Creatinine [bacs, orch]
Increased [qnco]
mg dl [qnco]
Kidney [bpoc]
Return [qlco]
Normal [qlco]
Levels [qlco]
days [tmco]
acipimox [orch, phsu]
interruption [ftcn]
days [tmco]
therapy [ftcn]
Group [idcn]
Total Cholesterol [lbpr]
P NOS [aapp, imft]
P NOS [aapp, imft]
Group [idcn]
Total Cholesterol [lbpr]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
Group [idcn]
Total Cholesterol [lbpr]
P NOS [aapp, imft]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
acipimox [orch, phsu]
Well [qlco]
Lipid lowering drug [phsu]
Clear [qlco]
effects [qlco]
Drug [phsu]
Renal Metabolism [ortf]
Survival [acty]
coronary [bpoc]
PTS [gngm]
